ES2119752T3 - 5-amino-5,6,7,8-tetrahidroquinolinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. - Google Patents

5-amino-5,6,7,8-tetrahidroquinolinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.

Info

Publication number
ES2119752T3
ES2119752T3 ES91120652T ES91120652T ES2119752T3 ES 2119752 T3 ES2119752 T3 ES 2119752T3 ES 91120652 T ES91120652 T ES 91120652T ES 91120652 T ES91120652 T ES 91120652T ES 2119752 T3 ES2119752 T3 ES 2119752T3
Authority
ES
Spain
Prior art keywords
arylalkyl
alkyl
formula
hydrogen
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120652T
Other languages
English (en)
Inventor
Richard Charles Effland
David M Fink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2119752T3 publication Critical patent/ES2119752T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION, SE REFIERE A TETRAHIDROQUINOLINAS Y COMPUESTOS RELACIONADOS. DE FORMA PARTICULAR, LA INVENCION SE REFIERE A TETRAHIDROQUINOLINAS,5,6,7,8-AMINO-5 DE LA FORMULA DONDE X-Y ES UN GRUPO DE LA FORMULA DE DONDE R ES HIDROGENO, ALKYL, ALKENYL, O ARYALKYL, O UN GRUPO DE LA FORMULA DONDE R ELEVADO 1 ES HIDROGENO, ALKYL, O ARYALKYL; R (AL CUADRADO) Y R ELEVADO 3 SON INDEPENDIENTEMENTE HIDROGENO, ALKYL, ARYLALKYL, DIARYLALKYL, CYCLOALKENYLALKYL, ALKOXY, ARYLALCXY, O ALKANOYL; R (AL CUADRADO) Y R ELEVADO 3 ADHERIDOS JUNTO CON EL ATOMO DE NITROGENO AL CUAL ESTAN ENLAZADOS, FORMAN UN GRUPO DE LA FORMULA: DE DONDE P, ES 0 O 1, UN GRUPO DE FORMULA: DONDE Z ES O, S, O UN GRUPO DE FORMULA NR ELEVADO 6, DE DONDE R ELEVADO 6, ES HIDROGENO, ALKYL, O ARYLALKYL; R ELEVADO 4 ES HIDROGENO, ALKYL O ARYLALKYL; Y M, ES 0, 1 O 2, Y N ES 1 O 2 O ISOMEROS OPTICOS Y GEOMETRICOS DE AQUELLOS, O UNA SAL FARMACOLOGICA ADMISIBLE DE LOS MISMOS, QUE SON EFICAZMENTE EMPLEADAS EN LOS DESARREGLOS DE LA MEMORIA. LA INVENCION DESARROLLA TAMBIEN UN PROCESO PARA LA PREPARACION DE ESTOS COMPUESTOS Y SU USO MEDICO.
ES91120652T 1990-12-03 1991-12-02 5-amino-5,6,7,8-tetrahidroquinolinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos. Expired - Lifetime ES2119752T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,811 US5110815A (en) 1990-12-03 1990-12-03 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use

Publications (1)

Publication Number Publication Date
ES2119752T3 true ES2119752T3 (es) 1998-10-16

Family

ID=24487491

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120652T Expired - Lifetime ES2119752T3 (es) 1990-12-03 1991-12-02 5-amino-5,6,7,8-tetrahidroquinolinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.

Country Status (17)

Country Link
US (2) US5110815A (es)
EP (1) EP0489379B1 (es)
JP (1) JP3090514B2 (es)
KR (1) KR100235506B1 (es)
AT (1) ATE168371T1 (es)
AU (1) AU639875B2 (es)
CA (1) CA2056793C (es)
DE (1) DE69129790T2 (es)
DK (1) DK0489379T3 (es)
ES (1) ES2119752T3 (es)
FI (1) FI915653A (es)
IE (1) IE914183A1 (es)
NO (1) NO914734L (es)
NZ (1) NZ240803A (es)
PT (1) PT99674B (es)
TW (1) TW211003B (es)
ZA (1) ZA919480B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112568A0 (en) * 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
IL112567A (en) * 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
IL112566A (en) * 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
KR0158065B1 (ko) * 1995-05-29 1998-12-01 스기야마 가즈히코 반도체 집적회로장치 및 그 제조방법
KR100648869B1 (ko) 1998-09-30 2007-02-28 다케다 야쿠힌 고교 가부시키가이샤 방광 배출력 개선제
TWI301760B (en) * 2004-02-27 2008-10-11 Merz Pharma Gmbh & Co Kgaa Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
JPH0322011A (ja) * 1989-06-19 1991-01-30 Nec Corp キーボード入力データ処理方式

Also Published As

Publication number Publication date
NO914734L (no) 1992-06-04
US5310914A (en) 1994-05-10
FI915653A (fi) 1992-06-04
CA2056793C (en) 2003-03-11
AU8835291A (en) 1992-06-04
KR100235506B1 (ko) 1999-12-15
FI915653A0 (fi) 1991-11-29
JPH04290872A (ja) 1992-10-15
NO914734D0 (no) 1991-12-02
JP3090514B2 (ja) 2000-09-25
DK0489379T3 (da) 1999-04-19
CA2056793A1 (en) 1992-06-04
EP0489379B1 (en) 1998-07-15
DE69129790T2 (de) 1999-05-06
NZ240803A (en) 1994-07-26
KR920012036A (ko) 1992-07-25
TW211003B (es) 1993-08-11
PT99674B (pt) 1999-05-31
EP0489379A1 (en) 1992-06-10
DE69129790D1 (de) 1998-08-20
US5110815A (en) 1992-05-05
ATE168371T1 (de) 1998-08-15
ZA919480B (en) 1992-08-26
PT99674A (pt) 1992-10-30
AU639875B2 (en) 1993-08-05
IE914183A1 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
FI901447A0 (fi) Menetelmä farmakologisesti aktiivisten 8-substituoitujen ksantiinijohdannaisten valmistamiseksi
DE69021755D1 (de) Benzopyranderivate und Verfahren zu ihrer Herstellung.
ES539446A0 (es) Un procedimiento para preparar un derivado de dihidropiridazinona
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
PT90725A (pt) Processo para a preparacao de novos compostos cefem
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
ES2119752T3 (es) 5-amino-5,6,7,8-tetrahidroquinolinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
MX11866A (es) Nuevas cicloalquilamidas y procedimiento para su preparacion.
ATE86866T1 (de) Antikrebs-zusammensetzung.
EP0123962A3 (en) Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition
DK0420224T3 (da) Anthihepatopatisk middel
DE69011748D1 (de) Biphenyl-Derivate, Verfahren zu deren Herstellung und deren Zwischenprodukte.
ES8207543A1 (es) Un procedimiento para la preparacion de nuevos derivados heterotriciclicos jaula.
MY105852A (en) New 2-methoxycarbonyl substituted n, n'' -di- (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
DE3781044D1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
RO93389A (ro) Procedeu pentru prepararea unor derivati de 4-fluortiolcarbanilida
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 489379

Country of ref document: ES